Перегляд вихідного коду сторінки Most Disregarded Formula For The TGF-beta inhibitor

Fig. 2 Relative PLAC4 mRNA expression levels in maternal plasma between the control and trisomy 21 (T21) group. Graph bars represent the average ��Ct value of the three replicates. The significant differences in ��Ct value between the control group ... Discussion PLAC4 mRNA is transcribed from chromosome 21 and [http://www.selleckchem.com/TGF-beta.html click here] expressed by the placenta in maternal plasma. PLAC4 mRNA in maternal plasma was fetal derived and cleared after delivery. The allelic ratios in maternal plasma correlated  with those in the placenta. Based on Tsui et al. [17] and Kido et al. [18]'s researches, we had previously acquired the identification that placental mRNA would be detectable in maternal and showed the highest absolute level of expression in the placenta together with the largest relative difference in expression levels between the placenta and maternal blood cells. Researchers then confirmed that PLAC4 mRNA could be detected in the plasma of women in all three trimesters of pregnancy, but not in the plasma of nonpregnant individuals. As PLAC4 mRNA expression level in maternal plasma during first trimester was lower than those during the second  and the third trimester [9], we collected a series of maternal plasma samples from same singleton pregnant women in second trimester with different gestational age (range, 17 to 21 weeks). Our study on the concentrations of PLAC4 mRNA suggested that plasma PLAC4 mRNA could be detectable in maternal plasma, which was in accordance with that of Lo et al. [9]'s research. Besides than those of 17 to 18 weeks our studies showed a higher level of expression in the gestation of 18 to 21 weeks than those of than those of 17 to 18 weeks among euploid pregnant women, which can provide pregnant women a deeper insight with suitable detection period (18 to 21 weeks) for the noninvasive prenatal detection of T21. Subsequently, the comparison of PLAC4 mRNA expression levels between the two groups were inspected. And the analyses show that there is no significant difference in plasma PLAC4 mRNA expression level between the control group (comprised of 25 euploid pregnancies) and the T21group (comprised of 20 T21 pregnancies). Our results displays a different viewpoint about what is mentioned above [7]. One of the possible reasons was probably  that there were individual differences in recruited samples with pregnant women. On the other hand, it could be correlated with the heterogeneity of cells derived from different fetal tissues [19]. Also it maybe because of dysregulation of genome-wide recombination in oocytes with nondisjoined chromosomes 21, which were based on Middlebrooks et al. [20]' recent study. Reports on transcriptomic analyses of other fetal tissues [21,22,23], including cerebellum, heart or fibroblasts, demonstrated that sets of over-expressed and under-expressed genes differ across different cell types. Volk et al.